Header cover image
  • Investing Ideas
  • Canadian Pharmaceuticals & Biotech High Return On Equity, Low Debt

Canadian Pharmaceuticals & Biotech High Return On Equity, Low Debt

Results

1

0 new

Stocks with a return on equity of over 30% and a debt to equity ratio below 1.

1 companies

Vaxil Bio

Market Cap: CA$737.0k

A biotechnology company, focuses on a novel drug discovery and development platform based on signal peptides for infectious diseases and cancer.

VXL

CA$0.18

7D

2.8%

1Y

-7.5%